Management of Greenlight Laser Plus Transurethral Resection of Prostate for Elderly Men

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2018 Aug 17

PMID 30113481

Citations 2

Authors

Zhi-Hua Zhang

Fei Luo

Yan-Hui Su

Jian Li

Affiliations

Soon will be listed here.

Abstract

The study is aiming to evaluate the treatment safety and efficacy of greenlight laser photovaporization of the prostate (PVP) combined with transurethral electrovaporization resection (TUVP) for elderly (≥ 70 years) men with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH/LUTS) with a large prostate volume (≥ 80 mL). One hundred twelve BPH/LUTS patients treated with PVP were divided into 2 groups according to prostate volume (PV), the outcomes of the 2 groups were assessed at 12 months after the operation. Patients in the PV ≥ 80 group (n = 51) had a higher level of maximum detrusor pressure (Pdet.max) than those in the PV < 80 group (n = 61) (97.14 ± 36.68 vs 70.70 ± 32.55, P < .001). Pdet.max level of the 2 groups was significantly decreased at the end of follow-up. International Prostate Symptom Score questionnaires (IPSS) score, maximum flow rate (Qmax), and residual urine volume (PVR) were significantly improved in comparison to the preoperative status (P < .001). PVP combined with TUVP can significantly improve outcomes (IPSS, Qmax, PVR) and is a safe and effective technique for elderly BPH/LUTS patients with a large prostate volume.

Citing Articles

Combination of 180-W GreenLight XPS laser and bipolar transurethral resection of prostate for the treatment of large prostates beyond 100 ml: a novel hybrid technique.

Tsai M, Chen C, Chiang P, Chiang P Int Urol Nephrol. 2023; 55(11):2741-2746.

PMID: 37505428 DOI: 10.1007/s11255-023-03723-w.

Efficacy and Safety of the Sandwich Method in Patients with Benign Prostate Hyperplasia: Bipolar Transurethral Resection with GreenLight Vaporization.

Lin T, Chang P, Shao I, Chen Y, Huang H, Hsu Y J Clin Med. 2022; 11(5).

PMID: 35268367 PMC: 8910987. DOI: 10.3390/jcm11051276.

References

Hueber P, Ben-Zvi T, Liberman D, Bhojani N, Gautam G, Deklaj T . Mid term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes < 60 cc, 60 cc-100 cc and > 100 cc. Can J Urol. 2012; 19(5):6450-8. View

Yamada Y, Furusawa J, Sugimura Y, Kuromatsu I . Photoselective Vaporization of the Prostate: Long-Term Outcomes and Safety During 10 Years of Follow-Up. J Endourol. 2016; 30(12):1306-1311. DOI: 10.1089/end.2016.0522. View

Altay B, Erkurt B, Kiremit M, Guzelburc V, Boz M, Albayrak S . 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci. 2014; 30(1):317-23. DOI: 10.1007/s10103-014-1667-4. View

Stone B, Chughtai B, Forde J, Tam A, Lewicki P, Te A . Safety and Efficacy of GreenLight XPS Laser Vapoenucleation in Prostates Measuring Over 150 mL. J Endourol. 2016; 30(8):906-12. DOI: 10.1089/end.2016.0288. View

Brunken C, Seitz C, Tauber S, Schmidt R . Transurethral GreenLight laser enucleation of the prostate--a feasibility study. J Endourol. 2011; 25(7):1199-201. DOI: 10.1089/end.2010.0550. View

Fu W, Hong B, Wang X, Yang Y, Cai W, Gao J . Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl. 2006; 8(3):367-71. DOI: 10.1111/j.1745-7262.2006.00134.x. View

Martin S, Haren M, Marshall V, Lange K, Wittert G . Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2010; 29(2):179-84. DOI: 10.1007/s00345-010-0605-8. View

Zang Y, Deng X, Yang D, Xue B, Xu L, Liu X . Photoselective vaporization of the prostate with GreenLight 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis of randomized controlled trials. Lasers Med Sci. 2015; 31(2):235-40. DOI: 10.1007/s10103-015-1843-1. View

Bachmann A, Tubaro A, Barber N, dAncona F, Muir G, Witzsch U . A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2014; 193(2):570-8. DOI: 10.1016/j.juro.2014.09.001. View

10.

Whitty J, Crosland P, Hewson K, Narula R, Nathan T, Campbell P . A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia. BJU Int. 2013; 113 Suppl 2:21-8. DOI: 10.1111/bju.12051. View

11.

Stone B, Chughtai B, Kaplan S, Te A, Lee R . GreenLight laser for prostates over 100 ml: what is the evidence?. Curr Opin Urol. 2015; 26(1):28-34. DOI: 10.1097/MOU.0000000000000237. View

12.

Albisinni S, Biaou I, Marcelis Q, Aoun F, De Nunzio C, Roumeguere T . New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives. BMC Urol. 2016; 16(1):58. PMC: 5024450. DOI: 10.1186/s12894-016-0176-0. View

13.

Park J, Cho S, Cho M, Jeong H, Son H . 5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia. PLoS One. 2017; 12(9):e0184442. PMC: 5597192. DOI: 10.1371/journal.pone.0184442. View

14.

Alivizatos G, Skolarikos A, Chalikopoulos D, Papachristou C, Sopilidis O, Dellis A . Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study. Eur Urol. 2007; 54(2):427-37. DOI: 10.1016/j.eururo.2007.11.044. View

15.

Chughtai B, Te A . Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices. 2011; 8(5):591-5. DOI: 10.1586/erd.11.25. View

16.

Yu Z, Li J, Li Z, Hou R . Photoselective Vaporization of the Prostate and Simultaneous Suprapubic Cystostomy for the Treatment of Benign Prostatic Hyperplasia in Patients with Mild to Severe Detrusor Underactivity. Urol Int. 2015; 95(3):269-75. DOI: 10.1159/000434688. View

17.

Gratzke C, Bachmann A, Descazeaud A, Drake M, Madersbacher S, Mamoulakis C . EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol. 2015; 67(6):1099-1109. DOI: 10.1016/j.eururo.2014.12.038. View

18.

Ruszat R, Wyler S, Seitz M, Lehmann K, Abe C, Bonkat G . Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non-randomized two-centre study. BJU Int. 2008; 102(10):1432-8. DOI: 10.1111/j.1464-410X.2008.07905.x. View

19.

Whelan J, Bowen J, Burke N, Woods E, McIssac G, Hopkins R . A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Can Urol Assoc J. 2013; 7(9-10):335-41. PMC: 3854472. DOI: 10.5489/cuaj.180. View

20.

Li Z, Hou R, Li J . The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms. Int Urol Nephrol. 2013; 46(4):691-4. DOI: 10.1007/s11255-013-0572-2. View